NJ’s Merck reports positive data on new cholesterol drug
NJ’s Merck reports positive data on new cholesterol drug Merck’s drug, similar to one that Pfizer was forced to abandon four years ago, helped patients in a study lower bad cholesterol and dramatically raise their good cholesterol. The data, reported at the American Heart Association meeting in Chicago, will revive interest in a class of [...]
Earnings Preview: Merck to report 2Q results
Earnings Preview: Merck to report 2Q results Merck & Co., a Dow component and the world’s second-biggest drug company by revenue, likely will focus on current cost-cutting and future drugs when it reports its second-quarter results before the stock market opens Friday. Read more on AP via Yahoo! Finance
Merck settles patent dispute on cholesterol drug
Merck settles patent dispute on cholesterol drug Merck & Co. said Monday it settled a patent dispute with Glenmark Pharmaceuticals on the cholesterol drug Zetia, one of its best-selling products. Read more on AP via Yahoo! News